Literature DB >> 26743536

Use of the VH6-1 gene segment to code for anti-interleukin-18 autoantibodies in multiple sclerosis.

Marina Tiumentseva1,2, Vera Morozova3, Aleksandr Zakabunin3, Denis Korobko4, Nadezhda Malkova4,5, Maksim Filipenko3, Nina Tikunova3.   

Abstract

We investigated whether levels and repertoires of anti-interleukin-18 (IL-18) autoantibodies (auto-Abs) differ in multiple sclerosis (MS) patients and healthy donors (HDs). IL-18 concentration in MS patients' sera was higher than in HD, but the level of anti-IL-18 auto-Abs was lower in MS patients. Correlation patterns of IL-18/anti-IL-18 auto-Abs system differed in HD and MS patients, so we have compared segment composition of the anti-IL-18 single-chain variable fragments (scFvs) selected from MS and naïve phage display libraries. Considerable differences between anti-IL-18 auto-Abs of these libraries were found. MS panel contained auto-Abs displaying both signs of "fetal" and somatically hypermutated repertoires. Naïve panel mainly contained the naïve antibodies. These variations from the norm are possible results of abnormal regulation of the repertoire perhaps determined by remodeling of the molecular mechanisms involved in the V(D)J recombination and/or abnormal selection by antigen in MS pathogenesis.

Entities:  

Keywords:  Autoantibodies; Immunoglobulin genes; Interleukin (IL)-18; Multiple sclerosis; Phage display

Mesh:

Substances:

Year:  2016        PMID: 26743536     DOI: 10.1007/s00251-015-0895-5

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  59 in total

1.  Single-cell repertoire analysis demonstrates that clonal expansion is a prominent feature of the B cell response in multiple sclerosis cerebrospinal fluid.

Authors:  Gregory P Owens; Alanna M Ritchie; Mark P Burgoon; R Anthony Williamson; John R Corboy; Donald H Gilden
Journal:  J Immunol       Date:  2003-09-01       Impact factor: 5.422

Review 2.  Interleukin-18, from neuroinflammation to Alzheimer's disease.

Authors:  P Bossù; A Ciaramella; F Salani; D Vanni; I Palladino; C Caltagirone; G Scapigliati
Journal:  Curr Pharm Des       Date:  2010       Impact factor: 3.116

3.  Developmental changes in the human heavy chain CDR3.

Authors:  M Margarida Souto-Carneiro; Gary P Sims; Hermann Girschik; Jisoo Lee; Peter E Lipsky
Journal:  J Immunol       Date:  2005-12-01       Impact factor: 5.422

Review 4.  Multiple sclerosis, seizures, and antiepileptics: role of IL-18, IDO, and melatonin.

Authors:  G Anderson; M Rodriguez
Journal:  Eur J Neurol       Date:  2010-11-30       Impact factor: 6.089

5.  Selection of naturally occurring autoantibodies to interleukin-18 from phage display library.

Authors:  M A Vikhrova; M V Shveygert; E A Khrapov; M L Filipenko; I P Gileva; V V Morozova; N V Tikunova
Journal:  Hum Antibodies       Date:  2010

Review 6.  Tumour necrosis factor and other proinflammatory cytokines in systemic lupus erythematosus: a rationale for therapeutic intervention.

Authors:  M Aringer; J S Smolen
Journal:  Lupus       Date:  2004       Impact factor: 2.911

7.  In vivo pro- and anti-inflammatory cytokines in normal and patients with rheumatoid arthritis.

Authors:  Suppiah Paramalingam Sivalingam; Julian Thumboo; Sheila Vasoo; Szu Tien Thio; Connie Tse; Kok Yong Fong
Journal:  Ann Acad Med Singapore       Date:  2007-02       Impact factor: 2.473

8.  Anti-cytokine autoantibodies in autoimmunity: preponderance of neutralizing autoantibodies against interferon-alpha, interferon-omega and interleukin-12 in patients with thymoma and/or myasthenia gravis.

Authors:  A Meager; M Wadhwa; P Dilger; C Bird; R Thorpe; J Newsom-Davis; N Willcox
Journal:  Clin Exp Immunol       Date:  2003-04       Impact factor: 4.330

Review 9.  Interferon: cellular executioner or white knight?

Authors:  S G Maher; A L Romero-Weaver; A J Scarzello; A M Gamero
Journal:  Curr Med Chem       Date:  2007       Impact factor: 4.530

10.  Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis.

Authors:  W I McDonald; A Compston; G Edan; D Goodkin; H P Hartung; F D Lublin; H F McFarland; D W Paty; C H Polman; S C Reingold; M Sandberg-Wollheim; W Sibley; A Thompson; S van den Noort; B Y Weinshenker; J S Wolinsky
Journal:  Ann Neurol       Date:  2001-07       Impact factor: 10.422

View more
  3 in total

1.  Nonspecificity in a nonimmune human scFv repertoire.

Authors:  Ryan L Kelly; Jessie Zhao; Doris Le; K Dane Wittrup
Journal:  MAbs       Date:  2017-09-14       Impact factor: 5.857

2.  An Autoantigen Profile of Human A549 Lung Cells Reveals Viral and Host Etiologic Molecular Attributes of Autoimmunity in COVID-19.

Authors:  Julia Y Wang; Wei Zhang; Michael W Roehrl; Victor B Roehrl; Michael H Roehrl
Journal:  bioRxiv       Date:  2021-02-22

3.  A Master Autoantigen-ome Links Alternative Splicing, Female Predilection, and COVID-19 to Autoimmune Diseases.

Authors:  Julia Y Wang; Michael W Roehrl; Victor B Roehrl; Michael H Roehrl
Journal:  bioRxiv       Date:  2021-08-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.